Revenue
2021
2022
2023
2026
| 2026 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue | £0 | £5.5M | £4.5M | £1.9M |
| Research & development | £392,000 | — | — | — |
| Operating expenses | £4.6M | £8.2M | £11.3M | £9.9M |
| Operating income | −£4.6M | −£4.3M | −£8.6M | −£8.8M |
| Operating margin | — | −77.00% | −192.59% | −464.04% |
| EBITDA | −£4.6M | −£3.4M | −£8.1M | −£8.8M |
| EBITDA margin | — | −61.72% | −182.93% | −461.99% |
| Net income | −£4.3M | −£4.5M | −£8.7M | −£8.8M |
| Net profit margin | — | −81.39% | −196.45% | −463.51% |
| Basic EPSper basic share | — | -£0.01 | -£0.02 | -£0.02 |
| Diluted EPSper diluted share | — | -£0.01 | -£0.02 | -£0.02 |